Skip to Main Content

Paper Details

Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.
Haemophilia
6
2016

Datasets

Release 1.2